Madrigal Pharmaceuticals

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Apr 22, 2026
Full time
Madrigal Pharmaceuticals Waltham, MA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Amsterdam, Netherlands
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Waltham, MA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Seattle, WA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Zug, Switzerland
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Munich, Germany
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Zug, Switzerland
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Apr 22, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).